abstract: Ovarian stimulation induced by follicle-stimulating hormone and human chorionic gonadotrophin (hCG) is commonly used in assisted reproductive technology to increase embryo production. However, recent clinical and animal studies have shown that ovarian stimulation disrupts endometrial function and embryo development and adversely affects pregnancy outcomes. How ovarian stimulation impairs pregnancy establishment and the precise mechanisms by which this stimulation reduces the chances of conception remain unclear. In this study, we first demonstrated that ovarian stimulation using hCG alone impairs implantation, decidualization and fetal development of mice by generating abnormal ovarian hormone levels. We also showed that ovarian hormone levels were altered because of changes in the levels of the enzymes involved in their synthesis in the follicles and corpora lutea. Furthermore, we determined that anomalous ovarian hormone secretion induced by ovarian stimulation alters the spatiotemporal expression of progesterone receptors and their downstream genes, especially in the uterine epithelium. Epithelial estrogenic signaling and cell proliferation were promoted on the day of implantation in stimulated mice and these changes led to the failure of uterine transition from the prereceptive to the receptive state. Collectively, our findings indicate that ovarian stimulation using hCG induces an imbalance in steroid hormone secretion, which causes a failure of the development of uterine receptivity and subsequent implantation and decidualization by altering the expression of steroid receptors and their downstream signaling associated with embryo implantation.
Introduction
Pregnancy is a complex process involving multiple critical stages: fertilization, preimplantation embryo development, oviductal embryo transport, embryo implantation, uterine decidualization and placentation. Failure at any of these stages compromises pregnancy outcomes and has been linked to infertility, which is now considered a bona-fide disease by the World Health Organization (Zegers-Hochschild et al., 2009) . Two million couples in USA and 15% of all couples worldwide face infertility problems and difficulty in conceiving a child. In women, infertility stems from defective oocyte development or uterine function. One approach used for tackling this problem is assisted reproductive technology (ART), which has improved embryo culture techniques substantially (de Mouzon et al., 2012) ; however, methods to effectively improve uterine function remain to be fully developed. Studies on animal models have shown that normal implantation, which is essential for successful pregnancy, only occurs when effective bidirectional communication is established between a receptive uterus and an implantation-competent blastocyst. The uterus becomes receptive as a result of the coordinated actions of ovarian progesterone and estrogen.
Stimulation of the ovary increases the number of oocytes and embryos that can be obtained for performing embryo transfer, which can increase the chance of successful implantation and pregnancy. In ART, the ovary stimulation commonly involves the use of human chorionic gonadotrophin (hCG): multifollicular development is induced using exogenous gonadotrophins, and hCG is injected in order to trigger oocyte maturation before retrieving oocytes to perform-in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Moreover, hCG is used to control ovulation in patients who conceive by means of intrauterine insemination (IUI) or timed intercourse.
Although ovarian stimulation is a promising approach, recent clinical studies have demonstrated that stimulation using exogenous hormones might be detrimental to pregnancy (Kolibianakis et al., 2002; Bourgain and Devroey, 2003; Kolibianakis et al., 2003 Kolibianakis et al., , 2005 Devroey et al., 2004; Papanikolaou et al., 2005) . The level of gonadotrophins used in IVF treatment is extremely high compared with the endogenous level of these hormones, which causes an increase in the levels of circulating serum estrogen and progesterone in patients and might be associated with alterations in the expression of specific receptors that interact with these steroid hormones . This, in turn, might influence the preparation of the endometrium for pregnancy (Horcajadas et al., 2007) and result in diminished endometrial receptivity following stimulation (Paulson et al., 1990) and reduced clinical implantation and pregnancy rates (Yu Ng et al., 2000) . However, because the effects of exogenous gonadotrophins on the endometrium cannot be examined during implantation in humans, the mechanism by which ovarian stimulation using hCG affects uterine receptivity in the endometrium has remained unclear.
Exogenous gonadotrophin is also used for ovarian stimulation in rodent models to induce ovulation induction. In rodents, ovarian stimulation performed by means of double-treatment with hCG and equine CG (eCG) has been reported to diminish the number of embryos in the late stage of gestation and thus lower the number of full-term pups. Furthermore, following similar ovarian stimulation in mice, embryonic and fetal development is delayed and the formation of pinopodes is also affected (Ertzeid and Storeng, 2001 ; Van der Auwera and D'Hooghe, 2001; Rashidi et al., 2012) . These adverse effects have also been observed in mice treated with hCG alone (Walton et al., 1982; Fossum et al., 1989; Ertzeid and Storeng, 1992) . These previous studies indicate that hCG treatment reduced the number of pups by causing a failure of either implantation or early pregnancy; however, the effects produced by hCG during peri-implantation have not been examined.
In this study, we show that treatment with hCG alone and doubletreatment with eCG and hCG (eCG/hCG) in mice causes defective implantation and decidualization. We also demonstrate that hCG treatment alters the balance in the synthesis and secretion of hormones in the ovary. This steroidal alteration leads to changes in the spatiotemporal expression of the receptors of these hormones in the endometrium. These results suggest that following ovarian stimulation, steroid hormones induce a disruption of endometrial signaling, which would indirectly affect implantation and decidualization.
Materials and Methods

Materials
We purchased eCG was from Aska Pharmaceutical (Tokyo, Japan) and hCG from Mochida Pharmaceutical (Tokyo, Japan). KSOM (potassium simplex optimized medium) and ApopTagw Peroxidase In Situ Apoptosis Detection Kit were purchased from Millipore (Billerica, MA, USA) and the enzyme immunoassay (EIA) kits used for measuring estradiol-17b and progesterone were obtained from Cayman Chemical Company (Ann Arbor, MI, USA). The commercial antibodies used in this study were against CD34 (Abcam, Cambridge, MA, USA), progesterone receptor (PR) (LifeSpan Biosciences, Seattle, WA, USA), Indian hedgehog (Ihh) (Abcam), estrogen receptor a (ERa) (Santa Cruz Biotechnology, Dallas, TX, USA), phosphorylated ERa (p-ERa) (Santa Cruz Biotechnology), mucin 1 (Muc1) (Novus Biologicals, Littleton, CO, USA) and Ki67 (Thermo Scientific, Waltham, MA, USA). A biotinylated goat anti-rabbit antibody (111-065) was purchased from Jackson ImmunoResearch (West Grove, PA, USA); a biotinylated donkey anti-goat antibody was purchased from Abcam; and biotinylated goat antirabbit (B2770) and goat anti-mouse antibodies, horseradish peroxidase (HRP)-conjugated streptavidin, 3-amino-9-ethylcarbazole (AEC), Trizol reagent, PureLink TM RNA mini kit, high-capacity RNA-to-cDNA kit, TaqMan w Gene Expression Assay kit and TaqMan w Fast Universal PCR Master Mix were purchased from Life Technologies (Carlsbad, CA, USA).
Animals
Institute of cancer research (ICR) female mice were obtained from Japan SLC Inc. (Shizuoka, Japan) and housed under a 12-h light/dark cycle. To induce follicular development and ovulation, we injected either hCG or eCG and hCG intraperitoneally into 7 -8-week-old female mice ( Fig. 1 ; Beaumont and Smith, 1975; Ertzeid and Storeng, 1992; Byers et al., 2012) . In the case of treatment with hCG alone, saline was injected into mice 2 days before mating and then 5 or 10 IU hCG was injected on the day of mating (Fig. 1B  and C ). In the case of treatment with both eCG and hCG, 5 or 10 IU eCG was injected into mice 2 days before mating and 5 or 10 IU hCG was injected on the day of mating (Fig. 1D and E) . In control mice, saline was injected 2 days before mating and on the day of mating (Fig. 1A) . After the final injection, the female mice were mated with 8 -10-week-old vasectomized or intact ICR male mice to induce pseudo-pregnancy or pregnancy, respectively (Day 1 ¼ vaginal plug). Pseudo-pregnant females were used for the evaluation of fetal development and implantation after embryo transfer or for decidualization evaluation by means of oil infusion. Females that became pregnant as a result of mating were used for analyzing implantation, examining ovarian hormone synthesis and secretion, and evaluating the expression of uterine steroid receptors and their downstream signaling. All animal studies were performed following the guidelines of the care and use of laboratory 
Embryo culture and transfer
Two-cell-stage embryos were collected from excised oviducts of donor mice on Day 2 of pregnancy and cultured until they reached the blastocyst stage; embryos were cultured for 72 h in KSOM at 378C in a 5%-CO 2 /95%-air atmosphere. For evaluating full-term development, embryo transfer and Cesarean sections were performed in all groups of mice shown in Fig. 1 as described previously (Matsumoto et al., 2011) . Briefly, 15 blastocysts were transferred into the uteri of pseudo-pregnant mice on Day 4 of pregnancy and Cesarean sections were performed in order to deliver live fetuses on Day 19 of pregnancy. For the evaluation of blastocyst implantation, 10 blastocysts were transferred into the uteri of pseudo-pregnant mice of groups A, C, and E shown in Fig. 1 on Day 4 of pregnancy, and the uteri were excised and used for the following experiments.
Analysis of blastocyst implantation
In order to visualize implantation sites, on Day 5 of pregnancy, Chicago blue dye solution was intravenously injected into females bearing the 10 transferred blastocysts or into naturally mated females in groups A, C and E shown in Fig. 1 (Paria et al., 1993) . Excised implantation sites were fixed in 10% neutral buffered-formalin (NBF) and then embedded in paraffin wax. Histological analysis and immunohistochemistry were performed on 5-mm-thick paraffin sections.
Induction of artificial decidualization
Artificial decidualization was induced in all groups of mice shown in Fig. 1 as described (Lim et al., 1997) . Briefly, female mice were mated with vasectomized males to induce pseudo-pregnancy and then sesame oil (25 ml) was infused into one side of the uterine horn to induce artificial decidualization. The wet weights of infused and non-infused (intact) uterine horns were recorded on Day 8. The fold-induction in uterine wet weights was used as an index for comparing artificial decidualization. The uterine horns collected were fixed in 10% NBF and then embedded in paraffin wax, and histological analysis was performed on 5-mm-thick paraffin sections stained with hematoxylin and eosin.
Measurement of serum levels of progesterone and estradiol-17b
We extracted 500 ml of blood from mice in order to collect the serum and then measured the serum progesterone and estrogen levels by using EIA kits (Cayman) according to the manufacturer's instructions.
Immunohistochemistry
Uterine sections were immunostained for CD34, PR, Ihh, ERa, p-ERa, Muc1 and Ki67 by using previously described procedures with slight modifications (Matsumoto et al., 2011) . Uterine horns were collected from hCG-or eCG/ hCG-treated mice on Days 1 -5 of pregnancy and fixed in 10% NBF to generate paraffin sections. Sections were deparaffinized in xylene, rehydrated using a graded ethanol series, and then blocked with 3% bovine serum albumin in Ca Terminal deoxynucleotidyl transferase dUTP nick end-labeling assay
Transferase dUTP nick end-labeling (TUNEL) assay was performed using the ApopTag-peroxidase in situ apoptosis detection kit. Briefly, sections on slides were deparaffinized in xylene and rehydrated using a graded ethanol series. The sections were next treated with proteinase K at room temperature (RT) for 15 min and incubated in 3% hydrogen peroxide for 15 min in order to inactivate endogenous peroxidases. After brief incubation with Equilibrium Buffer, the sections were incubated with Terminal Deoxynucleotidyl Transferase Buffer at 378C for 1 h. The terminal transferase was detected by staining with streptavidin/biotin/peroxidase at 378C for 30 min and then with AEC for 5 min. Lastly, the sections were counterstained with hematoxylin.
Quantitative RT-PCR analysis
Quantitative RT-PCR (qRT-PCR) assays were performed as described previously (Takehara et al., 2013) . Ovaries and uterine horns were collected and stored at 2808C until use. Total RNA was extracted using the Trizol reagent (Invitrogen, 15596-026) and then further purified using the PureLink TM RNA mini kit (12183018A). To obtain cDNAs, 5 mg of RNA was reverse transcribed using a high-capacity RNA-to-cDNA kit (4387406). The TaqMan w Gene Expression Assay was used for quantifying the mRNA levels of bone morphogenetic protein 2 (Bmp2, Mm01340178_m1), Wnt4 (Mm01194003_m1), follistatin (Fst, Mm00514982_m1), steroidogenic acute regulatory protein (StAR, Mm00441558_m1), CYP11A1 (Mm00490735_m1), HSD3B1 (Mm01261921_ mH), CYP17A1 (Mm00484040_m1), CYP19A1 (Mm00484049_m1), PR (Mm00435628_m1), homeobox A10 (Hoxa10, Mm00433966_m1), Ihh (Mm00439613_m1), amphiregulin (Areg, Mm01354339_m1), GATA binding protein 2 (Gata2, Mm00492301_m1), low-density lipoprotein receptor-related protein 2 (Lrp2, Mm01327960_m1), ERa (Mm00433149_m1), leukemia inhibitory factor (Lif, Mm00434762_g1), lactotransferrin (Ltf, Mm00434787_m1) and Muc1 (Mm00449604_m1). PCR amplification was performed in a total volume of 20 ml per reaction by using the TaqMan w Fast Universal PCR Master Mix (4352042) and a StepOnePlus TM Real-time PCR System (Applied Biosystems). Each sample was assayed in duplicate, and the expression of each target gene was normalized relative to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Mm99999915_g1). Relative gene expression was quantified according to the standard-curve method by using StepOne software Version 2.1.
Statistical analysis
x 2 tests were used for evaluating differences in the rates of pregnancy and birth of pups. The Fisher's exact probability test was used for comparisons when the expected values were ,5. Data obtained for the fold-increase in uterine weight, the number of implantation sites, serum estrogen and progesterone levels, and mRNA expression levels were distributed normally and analyzed using one-way analysis of variance (ANOVA), and the significance was determined using Fisher's PLSD (partial least-squares difference) post hoc multiple-comparison test; P , 0.05 was considered statistically significant.
Ovarian stimulation impairs uterine receptivity
Results
Exogenous gonadotrophin compromises embryo development by impairing uterine function
Our first objective was to determine how gonadotrophin affects the uterus during pregnancy. In preliminarily studies, we determined that treatment with exogenous gonadotrophin reduced the number of blastocysts recovered from uterine horns of pregnant mice on Day 4 after mating (Supplementary data, Fig. S1 ), which suggested that exogenous gonadotrophin adversely affects the in vivo development of embryos to blastocysts. To avoid the effects of exogenous gonadotrophin on embryonic development during the preimplantation stage and to adjust the number of blastocysts present in the uterus, we used the embryo transfer model: embryos recovered from donor mice were cultured in vitro and transferred to hormone-stimulated and control pseudo-pregnant mice. In this assay, we divided the animals into five experimental groups (Table I) , and the pseudo-pregnant females of these experimental groups received the embryo transfer (15 blastocysts per mouse). Our results showed that pregnancy rates, which were evaluated based on the presence of pups on the day of Caesarean section, were substantially lower in mice in all hormone treatment groups than in the control group. The number of pups and the weights of these pups in pregnant mice were also considerably lower in mice in all hormone treatment groups when compared with the corresponding values in the control group. This reduction was greater in mice in the eCG/hCG double-treatment groups than in the mice in the hCG single-treatment groups. These results are similar to the results of previous studies showing that eCG/ hCG double-treatment compromises embryo development (Fossum et al., 1989; Ertzeid and Storeng, 2001) . Notably, treatment with hCG alone also affected pregnancy outcomes, although these effects were milder than the effects of eCG/hCG double-treatment.
Exogenous gonadotrophin compromises implantation
Next, we sought to determine the site-and stage-specific effects of exogenous gonadotrophin during pregnancy. We first examined whether gonadotrophin affects blastocyst implantation, a critical step for successful pregnancy, by using the embryo transfer model. In this assay, pseudopregnant females received 10 blastocysts on Day 4 and uterine receptivity was assessed based on the number of implantation sites on Day 5. In mice treated with 10 IU hCG or 10 IU hCG and 10 IU eCG ( Fig. 1C and E), the number of implanted blastocysts was markedly decreased after embryo transfer when compared with the number in control mice, and the spacing of the sites was abnormal ( Fig. 2A and B). A similar phenomenon was observed in pregnant mice that were naturally mated with male mice after treatment with hCG or eCG/hCG (Supplementary data, Fig. S2A and B). Blastocysts typically attach and become implanted at the end of the lumen in the antimesometrial pole of the uterus; however, most of the blastocysts remained in the middle of the lumen and barely contacted the cells of the luminal epithelium (LE) in hCG-and eCG/hCG-treated mice (Fig. 2C) . Moreover, we evaluated angiogenesis in the endometrium surrounding the blastocysts by examining the distribution of CD34, a marker of newly formed vascular endothelial cells (Sakurai et al., 2003; Sugino et al., 2005) . The endometrial stromal tissue in hCG-and eCG/hCG-treated mice displayed less vascular permeability compared with that observed in the control animals ( Fig. 2D ). These results suggest that exogenous gonadotrophin disrupted the LE function required for implantation during periimplantation.
Artificial decidualization is impaired following treatment with eCG and hCG
In a regular pregnancy, the onset of decidualization requires embryonic stimulation. The embryonic signal that induces decidualization is transmitted from the embryo through the epithelium to the stroma starting from Day 5. Because hCG and eCG severely reduced implantation, we examined whether hCG and eCG also affect uterine function after implantation. To test the effects of the hormones on decidualization, we used artificial decidualization, which eliminates embryonic effects on the process. The blastocyst provides the natural decidualization stimulus; however, decidualization can also be induced experimentally by means of intraluminal oil infusion in pseudo-pregnant mice. We determined the extent of decidualization by comparing the fold-increases in uterine weight of infused and non-infused uterine horns on Day 8 of pseudopregnancy. Whereas artificial decidualization occurred in all control mice, it was compromised in the hormone-treated mice (Fig. 3 ). Treatment with hCG alone reduced the fold-increase in uterine weights and hCG/eCG double-treatment further lowered this value (Fig. 3B) . Moreover, the extent of this reduction increased in a hormone dosedependent manner. presence of decidual cells, whereas few decidual cells were observed in the sections of hormone-treated uteri (Fig. 3A) . The mRNA expression levels of Bmp2, Wnt4 and Fst, which are required for decidualization (Kaiser et al., 1990; Lee et al., 2007; Li et al., 2007) , were markedly lower in hCG-and eCG/hCG-treated mice than in control mice ( Fig. 3C -E) . These results demonstrated that treatment with hCG or hCG and eCG lowered the capacity for endometrial decidualization.
Serum estrogen and progesterone levels are aberrant in stimulated mice
In the natural cycle, follicle-stimulating hormone (FSH) induces follicular development and luteinizing hormone (LH) induces oocyte maturation and ovulation. Both FSH and LH are secreted from the pituitary and are necessary for programming the secretion of progesterone and estrogen by the ovary. Progesterone and estrogen are required for initiating implantation and optimal decidualization. In ovarian stimulation, eCG is used to induce follicular development and hCG is used to induce oocyte maturation and ovulation. Both eCG and hCG have been shown to alter the levels of progesterone and estrogen and compromise pregnancy outcomes (Miller and Armstrong, 1981; Miller and Armstrong, 1982; Kramer et al., 1990; Ertzeid and Storeng, 1992) . Thus, we measured the serum progesterone and estrogen levels during preimplantation (Days 1-4) in our system. The serum progesterone level was induced starting from Day 3 of pregnancy in control mice, whereas progesterone levels were higher in hCG-and eCG/hCG-treated mice than in control mice on Days 1-4 (Fig. 4A) . In control mice, the estrogen level was high on Day 1, then declined on Days 2 and 3, and finally was elevated again on Day 4 (Fig. 4B) . In hCG-treated mice, the level of estrogen on Day 1 was similar to that in control mice, but estrogen levels did not decline on Days 2 and 3 or increase on Day 4. In eCG/hCG-treated mice, estrogen levels were higher than those in control mice on Day 1, and the levels did not change markedly from Day 2 to Day 4. Previously, the expression levels of StAR and steroidogenic enzymes were demonstrated to be increased in hCG-treated granulosa cells in vitro as a result of LH/CG-receptor signaling and this lead to an alteration of estrogen and progesterone secretion (Su et al., 2006) . Because our results showed that ovarian steroid hormone levels were altered in both hCG-and eCG/hCG-treated mice, we examined the expression of StAR and steroidogenic enzymes in the ovaries of these hormone-treated mice. The expression of StAR mRNA was detected on Day 1 and this was increased from Day 2 onward in control mice, whereas the levels of this mRNA were higher in hCG-and eCG/hCG-treated mice than in control mice on Days 1-4 (Fig. 4C) . The mRNA expression of CYP11A1, which functions in the conversion of cholesterol to pregnenolone, was elevated on Day 4 in control mice, whereas its expression was higher than that in the controls on Days 1-4 in hCG-and eCG/ hCG-treated mice (Fig. 4D) . The mRNA expression of HSD3B1, which is responsible for transforming pregnenolone to progesterone, was increased on Day 4 in control mice, whereas its expression was elevated starting from Day 3 in hCG-treated mice (Fig. 4E) . In eCG/hCG-treated mice, HSD3B1 mRNA expression was higher than that in controls on Days 1-4. The mRNA level of CYP17A1, which is essential for the biosynthesis of androgens, was high on Day 1, from where it declined on Day 2 and then increased on Day 4 in control mice (Fig. 4F) . In hCG-treated mice, the CYP17A1 mRNA level was similar to that in control mice on Day 1 but when compared with the control, its level was higher on Days 2 and 3 and lower on Day 4. In eCG/hCG-treated mice, the expression of CYP17A1 mRNA was higher than that in control on Days 2-4. The mRNA expression of CYP19A1, which catalyzes the conversion of testosterone to estradiol, was high on Day 1, decreased on Day 2 and elevated again on Day 4 in control mice; by comparison, the level of this mRNA was lower on Day 1 and higher on Days 2 and 3 in hCG-and eCG/ Figure 3 Impaired uterine decidualization in stimulated mice. (A) Decidualization in stimulated mice after intrauterine oil infusion. The right horn (arrowhead) received oil infusion, whereas the left horn served as the control. In control mice, a deciduoma was formed in the oil-infused horn and decidual cells were observed in the endometrium (top panels). In contrast, decidualization and endometrial differentiation were not observed in mice treated with hCG alone or with both eCG and hCG. Scale bars represent 500 mm (low magnification: black) and 100 mm (high magnification: white). hCG-treated mice (Fig. 4G) . These results indicate that stimulation using only hCG unbalanced the expression patterns of cholesterol-transport proteins and steroidogenic enzymes in ovaries. The secretion patterns of serum estrogen and progesterone were aberrant probably because the expression of the steroidogenic enzymes was altered, and this would influence implantation and decidualization.
Progesterone receptor expression and downstream signaling are altered in the endometrium of stimulated mice Progesterone and estrogen function through their nuclear receptors PR and ERa in the uterus during pregnancy. Progesterone and estrogen are The expression of CYP11A1, which converts cholesterol to pregnenolone, was elevated in stimulated mice. Error bars represent the standard error of the mean. Bars labeled with distinct letters are significantly different from each other (P , 0.05). (E) HSD3B1 mRNA expression during the preimplantation period. The expression of HSD3B1, which transforms pregnenolone to progesterone, was increased in stimulated mice. Error bars represent the standard error of the mean. Bars labeled with distinct letters are significantly different from each other (P , 0.05). (F) CYP17A1 mRNA expression during the preimplantation period. The mRNA level of CYP17A1, which is essential for the biosynthesis of androgens, was abnormal in both hCG-and eCG/hCG-treated mice. Error bars represent the standard error of the mean. Bars labeled with distinct letters are significantly different from each other (P , 0.05). (G) CYP19A1 mRNA expression during the preimplantation period. The mRNA expression of CYP19A1, which aromatizes testosterone into estradiol, was aberrant in both hCG-and eCG/hCG-treated mice. Error bars represent the standard error of the mean. Bars labeled with distinct letters are significantly different from each other (P , 0.05).
recognized to regulate the spatiotemporal expression of PR and ERa in the uterus. Because we observed that the levels of progesterone and estrogen were altered in the stimulated mice during preimplantation, we examined the expression of PR in uteri during this stage. Using qRT-PCR, we determined that PR expression was extremely low on Days 1 and 2 and was increased from Day 3 onward in control mice; in the hormone-treated mice, although PR expression was extremely low on Day 1, it was elevated on Days 2 and 3, and then was decreased on Day 4 (Fig. 5B) . We also examined the spatiotemporal expression of PR by means of immunohistochemistry. In control uteri, PR was detected in stromal cells from Day 1 onward, and its expression was detected in the LE on Days 3 and 4 (Fig. 5A) . In the uteri of hormone-treated mice, PR expression was high in stromal cells on Days 2 and 3 and then decreased on Day 4, which agrees with the qRT-PCR results. In contrast, PR expression in the LE was either low or undetectable throughout the preimplantation period. These results showed that hormone treatment altered both the level and the localization of PR expression, especially in the LE, during preimplantation.
We next examined the PR downstream signaling that is critical for uterine receptivity. The Hoxa10 gene is downstream from PR and it is expressed in stromal cells during the implantation period (Lim et al., 1999) . The expression level of Hoxa10 mRNA was extremely low on Days 1 and 2 and then increased from Day 3 onward in control mice. In hCG-treated mice, Hoxa10 mRNA expression was extremely low on Day 1, was increased on Days 2 and 3, and then was decreased on Day 4 to a level lower than that in control mice. In eCG/hCG-treated mice, Hoxa10 mRNA was expressed at a similar level to that in control mice on Day 1, and then its expression was increased on Days 2 and 3 and later decreased on Day 4 to a level lower than that in control mice (Fig. 5C) .
Next, we used qRT-PCR and immunohistochemistry to assess the expression of the Ihh gene, which is downstream of epithelial PR (Matsumoto et al., 2002; Lee et al., 2006b) . In control mice, Ihh mRNA expression was undetectable on Days 1 and 2, was detected on Day 3, and was drastically increased on Day 4 (Fig. 5D) . In hCG-treated mice, Ihh mRNA expression was not detected on Days 1 and 2 and was extremely low on Days 3 and 4. In eCG/hCG-treated mice, Ihh mRNA was already expressed on Day 1 and this expression level remained constant until Day 4, but the mRNA was present at a lower level than that in control mice. The expression of Ihh protein was observed in the glandular epithelium (GE) of control mice on Days 3 and 4, whereas its expression was not observed in hCG-and eCG/hCG-treated mice (Supplementary data, Fig. S3 ). We further examined the mRNA expression of three other genes downstream of epithelial PR, Areg, Gata2 and Lrp2 Lee et al., 2006a; Rubel et al., 2012; Oh et al., 2013) . The expression of these genes in hCG-and eCG/hCG-treated mice was substantially lower on Days 3 and 4 compared with that in control mice (Fig. 5E -G) . These results showed that steroidogenic dysregulation caused by stimulation altered the expression of PR in both the epithelium and the stroma and also changed the expression of PR downstream genes associated with uterine receptivity in the endometrium during the preimplantation period.
Epithelial estrogenic activity persists during the implantation period in stimulated mice
Progesterone and estrogen act antagonistically and epithelial estrogenic activity is inhibited by epithelial and stromal PR signaling in the endometrium: estrogen stimulates the proliferation of uterine luminal and glandular epithelial cells in the adult mouse uterus (Huet-Hudson et al., 1989) ; in contrast, progesterone antagonizes the effects of estrogen on the proliferation of these epithelial cells and on the expression of Ltf and Muc1, and promotes the proliferation of uterine stromal cells by acting through progesterone -PR targets such as the Ihh gene (Martin et al., 1973b; Surveyor et al., 1995; Kurita et al., 2000; Takamoto et al., 2002; Jeong et al., 2005; Franco et al., 2010) . In stimulated mice, we observed that the expression patterns of PR and its downstream genes Ihh and Hoxa10 were altered. Therefore, we examined the expression of ERa and its downstream genes in order to determine whether the alteration of PR signaling affected the inhibition of estrogenic activity in the endometrium of stimulated mice during the preimplantation period.
Using qRT-PCR, we determined that ERa expression was detected on Days 1 and 2 and was increased from Day 3 onward in control mice. In the hormone-treated mice, ERa expression was detectable on Day 1 as in the case of the control mice and was increased on Day 2, after which the expression remained constant until Day 4, albeit at a level lower than that in control mice (Fig. 6B) . Next, we used immunohistochemistry to examine the spatiotemporal expression of ERa. In control uteri, ERa was detected in the LE and GE on Day 1, its level was decreased on Days 2 and 3, and then its expression in the LE, GE and stroma was increased on Day 4 (Fig. 6A ). In the uteri of hormone-treated mice, extremely low ERa expression was detected in a fraction of the epithelial cells on Day 1 and the expression increased slightly in the GE on Day 2. On Day 3, ERa was detected in the LE, GE and stroma, and its expression then decreased on Day 4. These results showed that hormone treatment altered both ERa expression levels and localization during the preimplantation period.
We also examined the phosphorylation of ERa (p-ERa), which is critical for the transcriptional activation of ERa (Kato et al., 1995) , by means of immunohistochemistry (Supplementary data, Fig. S4 ). Whereas p-ERa expression was not observed in the endometrial epithelium of control mice on Days 2-4, its expression was detected in the epithelium of hCG-treated mice on Days 2 and 3. In eCG/hCG-treated mice, the expression of p-ERa was observed in the epithelium on Days 2-4. Because the phosphorylation of ERa was altered following hormone treatment, we examined ERa downstream signaling. Lif is a member of the interleukin-6 family and one of the major mediators of estrogen action. Lif is essential for uterine receptivity and implantation, because its deletion causes implantation failure in mice (Stewart et al., 1992; Song et al., 2000) . Lif mRNA expression was high on Day 1, decreased on Day 2 and increased again on Day 4 in control mouse (Fig. 6C) . However, the expression was low on Days 1 -4 in hCG-and eCG/ hCG-treated mice. We also measured the mRNA expression of Ltf and Muc1, which are well-characterized estrogen-responsive genes that are specifically expressed in the uterine epithelium (Pentecost and Teng, 1987; Newbold et al., 1992; Surveyor et al., 1995) . High Ltf mRNA expression was detected on Days 1 and 2, but the level was markedly decreased on Days 3 and 4 in control mice. In hCG-treated mice, high Ltf mRNA expression was detected on Days 1 and 2, the level was decreased on Day 3, and then it was increased again on Day 4. In eCG/hCG-treated mice, a high level of Ltf mRNA expression was observed on Days 1-4 (Fig. 6D) . Muc1 is highly expressed in the uterine epithelium on Day 1 of pregnancy, and then its expression is down-regulated in the epithelium when uterine receptivity is attained on Day 4, an event that is essential for implantation (DeSouza et al., 1999) . In control mice, Muc1 mRNA expression was Ovarian stimulation impairs uterine receptivity Figure 6 Persistent epithelial ERa activity in hormone-treated mice during the implantation period. (A) Distribution of ERa in the endometrium during the preimplantation period. ERa expression was detected in the luminal epithelium of hCG-and eCG/hCG-treated uteri on Day 3, when ERa is normally down-regulated. Scale bars represent 100 mm. (B) ERa mRNA expression during the preimplantation period. Error bars represent the standard error of the mean. Bars labeled with distinct letters are significantly different from each other (P , 0.05). (C) Lif mRNA expression during the preimplantation period. The mRNA expression of Lif was aberrant during the preimplantation period in hCG-and eCG/hCG-treated mice. Error bars represent the standard error of the mean. Bars labeled with distinct letters are significantly different from each other (P , 0.05). (D) Ltf mRNA expression during the preimplantation period. The mRNA expression of Ltf, which is an epithelial ER-target gene, was markedly higher on Days 3 and 4 in hCG-and eCG/hCG-treated mice than in control mice. Error bars represent the standard error of the mean. Bars labeled with distinct letters are significantly different from each other (P , 0.05). (E) Muc1 mRNA expression during the preimplantation period. The mRNA expression of Muc1, which is an epithelial ER-target gene, persisted during the preimplantation period in hCG-and eCG/hCG-treated mice. Error bars represent the standard error of the mean. Bars labeled with distinct letters are significantly different from each other (P , 0.05). detected on Days 1 and 2 and then its level was decreased from Day 3 onward, a pattern of expression similar to that of Ltf. However, in the hormone-treated mice, Muc1 mRNA was expressed throughout Days 1-4 (Fig. 6E) . Immunohistochemical analysis showed that Muc1 protein expression decreased as pregnancy progressed in control mice, whereas its expression was observed in hormone-treated mice during the preimplantation period and on Day 4, the day of implantation (Supplementary  data, Fig. S5 ). These results suggest that estrogenic activity in the LE, which is typically down-regulated during the implantation period, was up-regulated during the preimplantation period in the stimulated mice.
In order to examine the pattern of cell proliferation and apoptosis in the uterus during the preimplantation period, we immunostained for Ki67 and performed TUNEL assays (Fig. 7) . Epithelial proliferation is promoted by estrogen-ER signaling and inhibited through stromal PR signaling, and stromal proliferation is initiated on Day 3 to prepare the uterus for implantation and decidualization (Martin et al., 1973a, b; Huet-Hudson et al., 1989; Li et al., 2011) . In control mice, Ki67 expression was first observed in the LE on Days 1 and 2, after which its expression shifted from the LE to the stroma and was increased from Day 3 onward (Fig. 7A) . In hCG-treated mice, Ki67-positive cells were observed in the LE on Day 1, as in the control mice. Subsequently, Ki67-positive cells in the LE were decreased and became detectable in the stroma on Day 2, but the Ki67-positive cells only sparsely populated both the LE and the stroma on Day 3. In eCG/hCG-treated mice, Ki67 expression was detected in both the LE and the stroma on Days 1 -4.
We performed TUNEL assays in order to examine the apoptosis pattern in the uterus during the preimplantation period. Cells of the rodent uterine epithelium have been widely reported to undergo apoptosis during the peri-implantation period (Schlafke et al., 1985; Parr et al., 1987; Welsh and Enders, 1991) . This epithelial apoptosis is essential for blastocyst implantation and it is controlled by estrogen-ER signaling (Yin et al., 2008) . TUNEL-positive cells were observed in epithelium of control mice on Day 4, but TUNEL-positive epithelial cells were not detected in hCG-and eCG/hCG-treated mice on Day 4 (Fig. 7B) . These results showed that hCG treatment altered the proliferation/ apoptosis pattern and differentiation status of uterine cells during the preimplantation period. This suggests that impaired PR signaling caused by anomalous levels of ovarian hormones is associated with an insufficient inhibition of estrogen signaling, which results in the disturbance of the uterine epithelial -stromal crosstalk that is required for uterine receptivity and subsequent implantation and decidualization.
Discussion
This is the first report to show that high doses of gonadotrophin compromise implantation and decidualization by altering ovarian hormone levels and downstream signaling. In this study, we first determined that both eCG/hCG treatment and treatment with hCG alone substantially reduced pregnancy rates, pup numbers and the weight of pups in mice. These results confirmed the previous finding that eCG/hCG doubletreatment compromises pregnancy outcomes in rodents (Walton et al., 1982; Fossum et al., 1989; Ertzeid and Storeng, 1992) . Although treatment with hCG alone was shown to adversely affect the pregnancy outcome, whether hCG affects embryonic development and/or endometrial functions has remained unknown (Ertzeid and Storeng, 1992) . In this study, by transferring in vitro cultured embryos to pseudo-pregnant mice treated with hCG, we are able to demonstrate that hCG affects the number of implantation sites. Therefore, we conclude that ovarian stimulation using both eCG and hCG or hCG alone leads to defective implantation and thereby diminishes full-term pregnancy rates.
The LE functions in controlling the induction of decidualization and blastocyst attachment (Lejeune et al., 1981) . In mice, epithelial cells detect the presence of blastocysts, or oil, in the lumen and then initiate the preparation for decidualization. We observed that decidualization capacity and endometrial angiogenesis were both diminished in stimulated mice, which indicates that the aberrant LE function caused by stimulation might lead to implantation failure and defective endometrial differentiation.
We also demonstrated that the expression of StAR and steroidogenic enzymes, which is stimulated by hCG through the LH/CG receptor, was aberrant, and that the pattern of estrogen and progesterone secretion was disrupted in the ovary in both hCG-and eCG/hCG-treated mice. Thus, we speculate that aberrant synthesis and secretion of steroid hormones are caused by the alteration of StAR and steroidogenic enzyme expression in the ovary of stimulated mice. The uterus is composed of several types of cells that undergo synchronized waves of proliferation and differentiation. These waves of changes primarily depend on coordinated interactions between the cells, which are mediated by ovarian estrogen and progesterone (Hall, 1969; Wang and Dey, 2006) . Although the LE promotes embryo implantation during the preimplantation period through these hormones, the stimulated mice exhibited anomalous steroidogenesis during the preimplantation period. The stimulationinduced alteration in ovarian steroidogenesis might derange the steroid signaling occurring in the endometrium.
PR functions downstream of the estrogen and progesterone pathways (Huet-Hudson et al., 1989; Das et al., 1998; Tibbetts et al., 1998) and is critical for establishing and maintaining pregnancy (Lydon et al., 1995; Fernandez-Valdivia et al., 2010) . During pregnancy, PR is transiently expressed in the LE immediately before embryo implantation (Tan et al., 1999; Spencer et al., 2004) . During embryo implantation, PR expression in the LE decreases rapidly and its expression in the uterine stroma increases and persists throughout decidualization (Diao et al., 2011) . Our results in control mice confirmed this phenomenon. In contrast, we observed abnormal PR expression in stimulated mice during the preimplantation period. Interestingly, stromal PR expression was increased but epithelial PR expression was inhibited in the stimulated mice throughout the preimplantation period. A previous study demonstrated that epithelial PR regulates the expression of epithelial progesterone-target genes and that deleting epithelial PR causes implantation defects and renders female mice infertile; these findings indicate that epithelial PR activity is essential for regulating uterine epithelialstromal crosstalk . Ma and colleagues showed that epithelial PR expression was down-regulated after treatment with a high dose of estrogen (Ma et al., 2003) , which suggests that the presence of high levels of ovarian estrogen during the preimplantation period caused epithelial PR inhibition.
To determine whether aberrant PR expression affects the endometrium in stimulated mice, we examined the expression of progesteronetarget genes. In stimulated mice, Hoxa10 mRNA expression started increasing on Day 2, but the level was lower than that in control mice on Day 4. Hoxa10 is a progesterone -PR target gene that is mainly expressed in the uterine stroma and is required on Day 4 of pregnancy. Hoxa10 is involved in stromal cell proliferation and differentiation and mutation of Hoxa10 causes specific defects in stromal cells that can lead to implantation and decidualization failure (Lim et al., 1999) . Therefore, our results suggest that stimulation-induced aberrant Hoxa10 expression would alter stromal functions and lead to reduced decidualization and poor post-implantation embryo development.
We observed that stimulation also inhibited the expression of the epithelial PR-target genes Ihh, Areg, Gata2 and Lrp2 by disrupting epithelial PR expression. Ihh is one of the key epithelial PR-target genes that plays a critical role during the initial implantation process (Matsumoto Takamoto et al., 2002; Jeong et al., 2005) , and Ihh interacts with its receptor and mediates PR actions in stromal cells (Lee et al., 2006b; Franco et al., 2010) . Conditionally knocking out the Ihh gene in the uterine epithelium causes a failure of embryo attachment and decidualization (Lee et al., 2006b) . Thus, dysregulation of ovarian steroidogenesis resulted in the inhibition of PR-Ihh signaling in the uterine epithelium of stimulated mice, which might be the main cause of LE dysfunction.
Ovarian hormones and endometrial PR signaling regulate epithelial estrogen signaling and cell cycle (Kurita et al., 2000; Franco et al., 2010) . Therefore, we examined the expression of ERa and its downstream genes in the endometrium of stimulated mice. Ovarian stimulation induced aberrant ERa expression and distribution in endometrium, and anomalous ERa phosphorylation was observed especially in the LE on Days 2 and 3, when ERa phosphorylation is normally down-regulated. Endometrial ERa expression is induced by estrogen (Couse et al., 1995; Das et al., 1998; Tibbetts et al., 1998; Tan et al., 1999) . Typically, preovulatory ovarian estrogen induces ERa expression in the uterine epithelium in mice, and then progesterone, secreted from the newly formed corpora lutea, inhibits estrogen signaling in epithelial cells on Day 3 of pregnancy. In stimulated mice, ovarian hormone secretion and endometrial PR signaling were compromised as a result of the stimulated expression of steroidogenic enzymes in the ovary, and these alterations led to aberrant ERa expression and phosphorylation, suggesting that PR signaling did not exhibit anti-estrogenic activity after stimulation.
We further evaluated estrogen-ER signaling activity by assessing the expression levels of the ER downstream genes, Lif, Muc1 and Ltf. Lif expression is localized in uterine glands on Day 4, and when blastocyst attachment occurs, its localization is shifted in stromal cells around the blastocyst (Stewart et al., 1992; Song et al., 2000) . Lif is essential for uterine receptivity and implantation, because its deletion leads to implantation failure (Stewart et al., 1992) . Our result showed that in stimulated mice, the Lif level remained low on Day 4, which would lead to impaired blastocyst implantation.
Muc1 is a major component of the apical glycocalyx that performs key functions at the luminal surface of the uterus. Muc1 plays barrier roles in the female reproductive tract by providing protection against bacterial pathogens, and Muc1 also functions in the reproductive processes (DeSouza et al., 1999) . Muc1 plays a dominant role in maintaining a functionally non-receptive uterine surface with regard to blastocyst attachment . On Day 4 of pregnancy, Muc1 expression was markedly decreased in the uterine epithelia of control mice, which is consistent with the attainment of a receptive status. However, Muc1 expression persisted in the LE in uteri of stimulated mice at the time of implantation. Whereas the down-regulation of Muc1 in the LE indicates that a uterus is receptive, persistent Muc1 expression inhibits the acquisition of uterine receptivity and embryo implantation (Surveyor et al., 1995; DeSouza et al., 1998 DeSouza et al., , 1999 , which indicating that ovarian stimulation may inhibit blastocyst implantation through Muc1. Ltf is also expressed in the LE and its expression level is controlled by estrogen, much like the level of Muc1 expression (Pentecost and Teng, 1987; Newbold et al., 1992) . Our results showed that in stimulated mice, the expression of Ltf on Day 4 also remained stable. Thus, we suggest that in stimulated mice, anomalous ER expression led to the absence of Lif and the persistent expression of Muc1 and Ltf, thereby disrupting uterine receptivity and causing implantation failure.
In the receptive uterus of mice on Day 4 of pregnancy, the proliferation of epithelial cells is complete and epithelial apoptosis is initiated before implantation (Finn and Martin, 1974; Carson et al., 2000; Sharma and Kumar, 2012) . In contrast, the uteri of stimulated mice exhibited atypical cell proliferation patterns in both the epithelium and the stroma. Furthermore, epithelial apoptosis was not observed in the endometrium of stimulated mice. Normally, pre-ovulatory ovarian estrogen stimulates the proliferation of luminal and glandular epithelial cells and suppresses the epithelial apoptosis (Huet-Hudson et al., 1989; Yin et al., 2008) . In contrast, progesterone inhibits the estrogen-mediated proliferation of these cells, and adding progesterone alone or in combination with estrogen leads to the proliferation of uterine stromal cells (Huet-Hudson et al., 1989; Tan et al., 1999) . Our results indicate that dysregulation of ovarian hormone synthesis caused by stimulation induces an abnormal pattern of cell proliferation and cell death in the uterine epithelium and stroma, and this would cause a failure of the transition from the prereceptive to the receptive state.
Collectively, our results indicate that: (i) when the ovary is stimulated using hCG, ovarian steroidogenesis is promoted and estrogen and progesterone are secreted at substantially higher levels than those observed during the early phase of a normal pregnancy, and (ii) this imbalance in the secretion of steroid hormones and their downstream signaling associated with embryo implantation causes a failure in the development of uterine receptivity and subsequent implantation and decidualization.
In mice, the uterine sensitivity to implantation is classified into prereceptive, receptive and refractory phases (Dey et al., 2004) . The uterus is receptive on Day 4 of pregnancy or pseudo-pregnancy, whereas it is prereceptive on Days 1 -3, and by the afternoon of Day 5, the uterus becomes refractory to implantation. In humans, the duration of the menstrual cycle (28 -30 days) is longer than the estrous cycle in mice (4 days), but a similar sequence of events occurs in humans during the secretory phase (Wang and Dey, 2006) . The prereceptive phase spans the first 7 days after ovulation (early luteal phase), and endometrial receptivity is achieved in the mid-luteal phase (7 -10 days after ovulation). The uterus then proceeds to the refractory phase for the remainder of the cycle (late luteal phase), until menstruation ensues. These sequential events are regulated by estrogen and progesterone in not only mice but also humans (Cha et al., 2012) . As in the case of the mouse uterus, estrogen stimulates ER and PR expression and progesterone inhibits ER expression in human endometria (Milgrom et al., 1973; Read et al., 1989; Bourgain and Devroey, 2003) . Therefore, in humans, optimal ovarian hormone synthesis and secretion are essential for the expression of ER and/or PR signaling and the consequent uterine transition into the receptive phase.
In human ART, exogenous gonadotrophins such as FSH and hCG are used to induce multifollicular development and ovulation, and this ovarian stimulation increases the levels of circulating serum estrogen and progesterone. Furthermore, hCG is used for inducing ovulation in patients who conceive by means of IUI or timed intercourse. A recent study demonstrated that high estrogen and progesterone levels induced by ovarian stimulation with hCG affected steroid receptor expression in endometrial tissues during the implantation window (Chai et al., 2011) . Therefore, pathways downstream from steroid receptors, such as PR-Ihh signaling, might also be impaired by hypersecreted ovarian estrogen and progesterone in humans; and this raises the possibility that the endometrial epithelium might not be able to effectively promote blastocyst implantation in patients who have received ovarian stimulation. Our findings suggest that ovarian stimulation using exogenous gonadotrophins indirectly affects implantation by disrupting normal ovarian function. Therefore, natural cycle IVF could serve as a favorable strategy for use in human ART in order to prevent the adverse effects that are potentially associated with ovarian stimulation.
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